8 Results for "

vascular restenosis

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "vascular restenosis" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-B1153
CAS No.: 3820-67-5
Synonyms: Glafenin
Glafenine (Glafenin) is a non-selective, non-steroidal anti-inflammatory drug-based COX-1/COX-2 inhibitor. Glafenine exerts anti-inflammatory, anti-proliferative and anti-cell migration effects by inhibiting the arachidonic acid metabolic pathway and reducing prostaglandin synthesis. Glafenine can induce cell cycle arrest in vascular smooth muscle cells and endothelial cells and reduce the synthesis of the extracellular matrix protein Tenascin. Glafenine can be used in the research of inflammatory-related diseases, vascular restenosis and cystic fibrosis (CF) .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-B1153A
CAS No.: 65513-72-6
Synonyms: Glafenin hydrochloride
Glafenine (Glafenin) hydrochloride is a non-selective, non-steroidal anti-inflammatory drug-based COX-1/COX-2 inhibitor. Glafenine hydrochloride exerts anti-inflammatory, anti-proliferative and anti-cell migration effects by inhibiting the arachidonic acid metabolic pathway and reducing prostaglandin synthesis. Glafenine hydrochloride can induce cell cycle arrest in vascular smooth muscle cells and endothelial cells and reduce the synthesis of the extracellular matrix protein Tenascin. Glafenine hydrochloride can be used in the research of inflammatory-related diseases, vascular restenosis and cystic fibrosis (CF) .
loading...
    loading...
Cat. No.: HY-B1153R
CAS No.: 3820-67-5
Synonyms: Glafenin (Standard)
Glafenine (Standard) is the analytical standard of Glafenine. This product is intended for research and analytical applications. Glafenine (Glafenin) is a non-selective, non-steroidal anti-inflammatory drug-based COX-1/COX-2 inhibitor. Glafenine exerts anti-inflammatory, anti-proliferative and anti-cell migration effects by inhibiting the arachidonic acid metabolic pathway and reducing prostaglandin synthesis. Glafenine can induce cell cycle arrest in vascular smooth muscle cells and endothelial cells and reduce the synthesis of the extracellular matrix protein Tenascin. Glafenine can be used in the research of inflammatory-related diseases, vascular restenosis and cystic fibrosis (CF) .
loading...
    loading...
Cat. No.: HY-112350
CAS No.: 226717-28-8
Target:  

PDGFR FLT3

Research Areas:  

Cancer

AGL 2043 is an effective inhibitor of PDGFR (IC50=0.8 μM) and TEL-PDGFR kinases, as well as FLT3 and KIT kinases. AGL 2043 can effectively inhibit porcine cardiac smooth muscle cell proliferation and balloon-induced vascular stenosis, and is suitable for development as an anti-restenotic and anticancer agent .
loading...
    loading...
Cat. No.: HY-117644
CAS No.: 159590-37-1
Synonyms: (Rac)-L-754142
Target:  

Endothelin Receptor

Research Areas:  

Cardiovascular Disease

L-749329 ((Rac)-L-754142) is an ETA and ETB receptor antagonist, with Kis of 0.062 nM and 2.25 nM for ETA and ETB respectively. L-749329 inhibits ET-1-stimulated signaling .
loading...
    loading...
Cat. No.: HY-B1153AR
CAS No.: 65513-72-6
Synonyms: Glafenin hydrochloride (Standard)
Glafenine (hydrochloride) (Standard) is the analytical standard of Glafenine (hydrochloride). This product is intended for research and analytical applications. Glafenine (Glafenin) hydrochloride is a non-selective, non-steroidal anti-inflammatory drug-based COX-1/COX-2 inhibitor. Glafenine hydrochloride exerts anti-inflammatory, anti-proliferative and anti-cell migration effects by inhibiting the arachidonic acid metabolic pathway and reducing prostaglandin synthesis. Glafenine hydrochloride can induce cell cycle arrest in vascular smooth muscle cells and endothelial cells and reduce the synthesis of the extracellular matrix protein Tenascin. Glafenine hydrochloride can be used in the research of inflammatory-related diseases, vascular restenosis and cystic fibrosis (CF) .
loading...
    loading...
Cat. No.: HY-106111A
CAS No.: 97901-22-9
Synonyms: DP-1904
Nafagrel hydrochloride is a Thromboxane A2 synthase inhibitor. Nafagrel hydrochloride inhibits the production of Thromboxane A2 and increases the production of Prostaglandin I2 (HY-A0126A). Nafagrel hydrochloride prevents thrombotic material accumulation in acute arterial thrombosis models. Nafagrel hydrochloride can be used in research on peripheral vascular disease, restenosis after PTCA, and lupus nephritis .
loading...
    loading...
Cat. No.: HY-W746425
CAS No.: 500733-49-3
Research Areas:  

Neurological Disease Cancer

Rapamycin dialdehyde is a non-immunosuppressive macrolide dialdehyde that promotes neuronal regeneration and functional recovery by inducing neurite outgrowth, and inhibits solid tumor cell growth and hyperproliferative vascular diseases. Rapamycin dialdehyde is used in the research of neurodegenerative diseases and cancer .
loading...
    loading...